CG ONCOLOGY INC. Share Price Today: Live Updates & Key Insights
CG ONCOLOGY INC. share price today is $69.32, up -2.53%. The stock opened at $70.47 against the previous close of $71.12, with an intraday high of $70.47 and low of $69.
CG ONCOLOGY INC. Share Price Chart
CG ONCOLOGY INC.
CG ONCOLOGY INC. Share Price Performance
CG ONCOLOGY INC. Institutional Holdings
CG ONCOLOGY INC. Market Status
CG ONCOLOGY INC. Fundamentals
Market Cap 6272.96 M
PB Ratio 5.5962
PE Ratio 0.0
Enterprise Value 5044.65 M
Total Assets 791.59 M
Volume 368760
CG ONCOLOGY INC. Company Financials
About CG ONCOLOGY INC. & investment objective
Company Information CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company's product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Dallas, Texas.
Organisation Biotechnology
Employees 142
Industry Biotechnology
CEO Mr. Arthur Kuan
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
CG ONCOLOGY INC. FAQs
What is the share price of CG ONCOLOGY INC. today?
The current share price of CG ONCOLOGY INC. is $69.32.
Can I buy CG ONCOLOGY INC. shares in India?
Yes, Indian investors can buy CG ONCOLOGY INC. shares by opening an international trading and demat account with Motilal Oswal.
How to buy CG ONCOLOGY INC. shares in India?
You can easily invest in CG ONCOLOGY INC. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy CG ONCOLOGY INC. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of CG ONCOLOGY INC..
Can I buy fractional shares of CG ONCOLOGY INC.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of CG ONCOLOGY INC.?
CG ONCOLOGY INC. has a market cap of $6272.96 M.
In which sector does CG ONCOLOGY INC. belong?
CG ONCOLOGY INC. operates in the Biotechnology sector.
What documents are required to invest in CG ONCOLOGY INC. stocks?
To invest, you typically need:
What is the PE and PB ratio of CG ONCOLOGY INC.?
The PE ratio of CG ONCOLOGY INC. is N/A and the PB ratio is 5.60.